279
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Use of the Average Baseline Versus the Time-Matched Baseline in Parallel Group Thorough QT/QTc Studies

, , , &
Pages 665-682 | Received 01 Jul 2009, Accepted 12 Nov 2009, Published online: 21 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Dalong (Patrick) Huang, Janell Chen & Yi Tsong. (2021) Baseline selection in concentration-QTc modeling: impact on assay sensitivity. Journal of Biopharmaceutical Statistics 31:2, pages 168-179.
Read now
Guowen (Gordon) Sun, Hui Quan, Robert Kringle & Zhaoling Meng. (2012) Comparison of Statistical Models Adjusting for Baseline in the Analysis of Parallel-Group Thorough QT/QTc Studies. Journal of Biopharmaceutical Statistics 22:3, pages 438-462.
Read now
Zhaoling Meng, Robert Kringle, Xun Chen & Peng-Liang Zhao. (2010) Sample Size Calculation for Thorough QT/QTc Study Considering Various Factors Related to Multiple Time Points. Journal of Biopharmaceutical Statistics 20:3, pages 580-594.
Read now

Articles from other publishers (12)

Jeppe Ekstrand Halkjær Madsen, Thomas Scheike & Christian Pipper. (2023) Unbiased and efficient estimation of causal treatment effects in crossover trials. Biometrical Journal 65:8.
Crossref
Yuhao Deng, Fangyi Chen, Yang Li, Kaihuan Qian, Rui Wang & Xiao‐Hua Zhou. (2021) A powerful test for the maximum treatment effect in thorough QT/QTc studies. Statistics in Medicine 40:8, pages 1947-1959.
Crossref
Yasushi Orihashi, Yuji Kumagai & Kazuhito Shiosakai. (2020) Novel concentration‐QTc models for early clinical studies with parallel placebo controls: A simulation study . Pharmaceutical Statistics 20:2, pages 375-389.
Crossref
Kaifeng Lu. (2014) An efficient analysis of covariance model for crossover thorough QT studies with period-specific pre-dose baselines. Pharmaceutical Statistics 13:6, pages 388-396.
Crossref
David Hoffman. (2014) Circadian Variation and Baseline Definition in Parallel-Group Thorough QT Studies. Therapeutic Innovation & Regulatory Science 48:2, pages 272-286.
Crossref
Kaifeng Lu. (2013) An efficient analysis of covariance model for crossover thorough QT studies with period-specific baseline days. Pharmaceutical Statistics 12:4, pages 192-200.
Crossref
Kaifeng Lu. (2012) An efficient and robust analysis of covariance model for baseline adjustment in parallel‐group thorough QT/QTc studies. Statistics in Medicine 32:14, pages 2406-2418.
Crossref
Claus Graff. (2013) Choice of Baseline in Parallel Thorough QT Studies. Drug Safety 36:6, pages 389-392.
Crossref
Joanne Zhang, Qianyu Dang & Marek Malik. (2013) Baseline Correction in Parallel Thorough QT Studies. Drug Safety 36:6, pages 441-453.
Crossref
Henry H. Holzgrefe, Georg Ferber, Royce Morrison, Olivier Meyer, Andrea Greiter‐Wilke & Thomas Singer. (2013) Characterization of the Human QT Interval: Novel Distribution‐Based Assessment of the Repolarization Effects of Moxifloxacin. The Journal of Clinical Pharmacology 52:8, pages 1222-1239.
Crossref
CHARLES M. BEASLEY, Jr.CHARLES BENSON, JESSIE Q. XIA, S. STANLEY YOUNG, HARRY HABER, MALCOLM I. MITCHELL & CORINA LOGHIN. (2011) Systematic Decrements in QTc between the First and Second Day of Contiguous Daily ECG Recordings under Controlled Conditions. Pacing and Clinical Electrophysiology 34:9, pages 1116-1127.
Crossref
Lawrence Z. Satin, Todd A. Durham & J. Rick Turner. (2011) Assessing a Drug’s Proarrhythmic Liability: An Overview of Computer Simulation Modeling, Nonclinical Assays, and the Thorough QT/QTc Study. Drug Information Journal 45:3, pages 357-375.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.